Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 686 of 1,261
  1. US 9382277

    Pyrimido-pyridazinone compounds and methods of use thereof

    Asana BioSciences, LLC · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted
  2. US 9382230

    Methods and compositions for modulating Ire1, SRC and ABL activity

    The Regents of the University of California · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted
  3. US 9382214

    Processes for the preparation of uracil derivatives

    Neurocrine Biosciences, Inc. · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted
  4. US 9381254

    Methods for preparing polymeric reagents

    Nektar Therapeutics · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted
  5. US 2016185873

    MONOCLONAL ANTIBODIES FOR TREATMENT OF CANCER

    GANYMED PHARMACEUTICALS AG [DE] · Granted Jun 30, 2016 · Expires Jun 25, 2036

    granted
  6. US 9375438

    Inhibitors of NCCa-ATP channels for therapy

    The United States of America as Represented by the Dept. of Veterans Affairs · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  7. US 9375402

    Oral formulations of kinase inhibitors

    VERASTEM, INC. · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  8. US 9376448

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  9. US 9375423

    Use of aminoindane compounds in treating overactive bladder and interstitial cystitis

    Asana BioSciences, LLC · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  10. US 9376681

    miR-29 mimics and uses thereof

    MIRAGEN THERAPEUTICS, INC. · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  11. US 9376690

    Templated nanoconjugates

    Northwestern University · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  12. US 9376683

    Organic compositions to treat beta-ENaC-related diseases

    Arrowhead Pharmaceuticals, Inc. · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  13. US 9376481

    Methods of promoting CNS neuronal repair by inhibiting LRP-1

    The Regents of the University of California · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  14. US 9376442

    Methylpyrrolopyrimidinecarboxamides

    TAKEDA GMBH · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  15. US 9376480

    Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  16. US 9376680

    Serpinc1 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  17. US 9375486

    Oligomer-containing benzamide-based compounds

    Nektar Therapeutics · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  18. US 9375474

    Compounds useful for inhibiting metastasis from cancer and methods using same

    Alliance Discovery, Inc. · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  19. US 9375475

    Combination immunotherapy for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  20. US 9375453

    Methods for producing bioeffective krill oil compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  21. US 9375441

    Lactulose for bowel evacuation

    Cumberland Pharmaceuticals Inc. · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  22. US 9375424

    Compounds that treat malaria and prevent malaria transmission

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  23. US 9375484

    Taxane silicate prodrugs and nanoparticles

    Regents of the University of Minnesota · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  24. US 9375403

    Formulations of 6-mercaptopurine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.